Key Takeaways
- • Flagler Health, an AI-native musculoskeletal healthcare platform, closed a $50 million Series B funding round led by Bessemer Venture Partners, bringing cumulative capital raised to $63 million.
- • The round included participation from eight investors: SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Venture Partners, and Offscript, signaling broad institutional confidence in the MSK care technology thesis.
- • Flagler's platform integrates clinical and administrative workflows across the patient lifecycle within existing electronic medical records (EMRs), positioning it as infrastructure for the largest and most underserved healthcare specialty.
- • Founded by physicians and MSK clinic operators, Flagler targets the fragmented musculoskeletal care market—a substantial but historically underinvested sector of healthcare—with AI-driven operational solutions.
Summary
Flagler Health announced a $50 million Series B funding round on August 11, 2026, led by Bessemer Venture Partners with participation from a broad consortium of venture investors. The financing brings the company's total capital raised to $63 million since inception, reflecting strong institutional appetite for healthcare AI solutions targeting operational inefficiency in specialty care.
The company positions itself as an AI-native operating system for musculoskeletal (MSK) healthcare, a sector representing the largest yet most underserved specialty within healthcare. Flagler's platform architecture seamlessly coordinates clinical and administrative workflows across the full patient lifecycle while integrating directly with providers' existing electronic medical records systems, eliminating the costly and disruptive need for system replacement.
Founded by physicians and healthcare operators with direct experience running MSK clinics, Flagler combines clinical domain expertise with operational acumen. The company is headquartered in New York and focuses on addressing the structural inefficiencies that have historically plagued fragmented musculoskeletal care delivery. The breadth of the Series B investor syndicate—including both generalist venture firms (Bessemer, SignalFire, Alumni Ventures) and specialized healthcare investors (Streamlined, 186 Ventures)—indicates convergence around AI-driven solutions for healthcare operational challenges.
The funding deployment will likely support product expansion, market penetration among MSK providers, and continued development of AI capabilities to automate clinical and administrative processes within the MSK care workflow.
The company positions itself as an AI-native operating system for musculoskeletal (MSK) healthcare, a sector representing the largest yet most underserved specialty within healthcare. Flagler's platform architecture seamlessly coordinates clinical and administrative workflows across the full patient lifecycle while integrating directly with providers' existing electronic medical records systems, eliminating the costly and disruptive need for system replacement.
Founded by physicians and healthcare operators with direct experience running MSK clinics, Flagler combines clinical domain expertise with operational acumen. The company is headquartered in New York and focuses on addressing the structural inefficiencies that have historically plagued fragmented musculoskeletal care delivery. The breadth of the Series B investor syndicate—including both generalist venture firms (Bessemer, SignalFire, Alumni Ventures) and specialized healthcare investors (Streamlined, 186 Ventures)—indicates convergence around AI-driven solutions for healthcare operational challenges.
The funding deployment will likely support product expansion, market penetration among MSK providers, and continued development of AI capabilities to automate clinical and administrative processes within the MSK care workflow.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.